Biospecifics Tech Cp (BSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1991 | 12-1990 | 12-1989 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 77 | 464 | 377 |
| Marketable Securities | 199 | 178 | 202 |
| Receivables | 537 | 589 | 637 |
| Inventories | 809 | 461 | 238 |
| Other current assets | 127 | 57 | 22 |
| TOTAL | $1,749 | $1,749 | $1,476 |
| Non-Current Assets | |||
| PPE Net | 1,020 | 624 | 569 |
| Other Non-Current Assets | 741 | 336 | 127 |
| TOTAL | $1,761 | $960 | $696 |
| Total Assets | $3,510 | $2,708 | $2,171 |
| Liabilities | |||
| Current Liabilities | |||
| Short Term Debt | 55 | 51 | 47 |
| Accounts payable and accrued liabilities | 836 | 863 | 860 |
| Other current liabilities | 259 | 236 | 87 |
| TOTAL | $1,302 | $1,548 | $1,848 |
| Non-Current Liabilities | |||
| Long Term Debt | 91 | 101 | 152 |
| Other Non-Current Liabilities | 53 | 134 | 130 |
| TOTAL | $144 | $235 | $282 |
| Total Liabilities | $1,393 | $1,764 | $2,131 |
| Shareholders' Equity | |||
| Common Shares | 2 | 2 | 2 |
| Retained earnings | 1,792 | 727 | -159 |
| Other shareholders' equity | 75 | 0 | 0 |
| TOTAL | $2,065 | $926 | $40 |
| Total Liabilities And Equity | $3,457 | $2,689 | $2,171 |